Prestige Consumer Healthcare (PBH) Change in Account Payables (2010 - 2025)

Prestige Consumer Healthcare's (PBH) quarterly Change in Account Payables came in at -$4.1 million in Q4 2025, up 63.68% year-on-year from -$2.5 million in Q4 2024, and down 120.66% quarter-over-quarter from $19.8 million in Q3 2025.

Prestige Consumer Healthcare (PBH) Change in Account Payables (2010 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Change in Account Payables history runs 16 years deep, the most recent figure standing at -$4.1 million for Q4 2025.

  • On a quarterly basis, Change in Account Payables rose 63.68% year-over-year to -$4.1 million in Q4 2025; TTM through Dec 2025 was $17.9 million, a 190.12% increase from a year earlier, with the FY2025 full-year figure at -$19.4 million, up 22.27% from the prior year.
  • Change in Account Payables fell to -$4.1 million in Q4 2025 per PBH's latest filing, from $19.8 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $19.8 million in Q3 2025 and bottomed at -$15.6 million in Q2 2021.
  • The 5-year median for Change in Account Payables is -$783500.0 (2024), against an average of $446700.0.
  • Across the five-year window, Change in Account Payables tumbled 766.38% in 2023 and surged 366.33% in 2025, its largest moves.
  • Year by year, Change in Account Payables stood at $2.2 million in 2021, then soared by 258.65% to $7.9 million in 2022, then tumbled by 165.31% to -$5.1 million in 2023, then sank by 118.8% to -$11.3 million in 2024, then surged by 63.68% to -$4.1 million in 2025.
  • Per Business Quant, the three latest PBH Change in Account Payables figures stand at -$4.1 million (Q4 2025), $19.8 million (Q3 2025), and $2.8 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Haleon 89.55 Bn 87.69 Bn - -
2 Teva Pharmaceutical Industries 36.00 Bn 32.26 Bn 1.97 Bn -
3 Zoetis 32.59 Bn 30.65 Bn 1.62 Bn 62.00 Mn
4 Takeda Pharmaceutical 27.52 Bn 23.45 Bn 4.39 Bn 30.60 Mn
5 United Therapeutics 23.07 Bn 20.91 Bn 648.10 Mn -
6 RedHill Biopharma 21.48 Bn 21.48 Bn - -
7 Viatris 20.28 Bn 18.47 Bn 1.16 Bn 32.70 Mn
8 Neurocrine Biosciences 17.78 Bn 16.47 Bn 800.70 Mn -
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Prestige Consumer Healthcare 2.44 Bn 2.38 Bn 157.37 Mn -4.09 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -4.09 Mn
Dec 31, 2025 -4.09 Mn
Sep 30, 2025 19.79 Mn
Sep 30, 2025 19.79 Mn
Jun 30, 2025 2.76 Mn
Jun 30, 2025 2.76 Mn
Mar 31, 2025 -560,000.00
Mar 31, 2025 -560,000.00
Dec 31, 2024 -11.26 Mn
Dec 31, 2024 -11.26 Mn
Sep 30, 2024 -8.19 Mn
Sep 30, 2024 -8.19 Mn
Jun 30, 2024 591,000.00
Jun 30, 2024 591,000.00
Mar 31, 2024 -1.01 Mn
Mar 31, 2024 -1.01 Mn
Dec 31, 2023 -5.14 Mn
Dec 31, 2023 -5.14 Mn
Sep 30, 2023 -13.22 Mn
Sep 30, 2023 -13.22 Mn